Finance

Lists
532296:BOM
Glenmark Pharmaceuticals Ltd
၂,၂၂၄.၀၀ ₹
-၁.၁၇%
(-၂၆.၃၀) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532296...
Open
၂,၂၄၉.၈၀ ₹
High
၂,၂၆၄.၀၀ ₹
Low
၂,၂၂၄.၀၀ ₹
Mkt. cap
ဋေ ၆.၂၈ သ
Avg. vol.
၁.၈၀ သောင်း
Volume
၁.၂၉ သောင်း
Dividend
၀.၂၂%
Quarterly dividend
၁.၂၅ ₹
Ex-dividend date
၂၀၂၅ အောက် ၃
P/E ratio
၃၄.၉၂
52-wk high
၂,၅၃၆.၈၅ ₹
52-wk low
၁,၇၉၄.၀၀ ₹
EPS
၆၃.၆၈ ₹
Shares outstanding
၀.၀၀
No. of employees
၂ သောင်း
Open
၂,၂၄၉.၈၀ ₹
High
၂,၂၆၄.၀၀ ₹
Low
၂,၂၂၄.၀၀ ₹
Mkt. cap
ဋေ ၆.၂၈ သ
Avg. vol.
၁.၈၀ သောင်း
Volume
၁.၂၉ သောင်း
Dividend
၀.၂၂%
Quarterly dividend
၁.၂၅ ₹
Ex-dividend date
၂၀၂၅ အောက် ၃
P/E ratio
၃၄.၉၂
52-wk high
၂,၅၃၆.၈၅ ₹
52-wk low
၁,၇၉၄.၀၀ ₹
EPS
၆၃.၆၈ ₹
Shares outstanding
၀.၀၀
No. of employees
၂ သောင်း
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၂၂ မိနစ်
Freshworks (FRSH) Shares Just Moved, So What Is Going On?
KuCoin
KuCoin
·
ပြီးခဲ့သည့် ၁၂ မိနစ်
Nasdaq posts its worst weekly decline since June, gold rebounds but faces resistance at 4200
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
Iambic Therapeutics (IAM) Joins The Nasdaq Composite, Is The Stock Already Pricey?
MarketWatch
MarketWatch
·
ပြီးခဲ့သည့် ၁ ရက်
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd
CEO-
Employees၁.၆၉ သောင်း
Founded၁၉၇၇
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၆.၀၅ ထ
ဋေ ၃.၉၀ ထ
ဋေ ၃.၈၃ ထ
ဋေ ၄.၀၂ ထ
Cost of goods sold
ဋေ ၁.၂၆ ထ
ဋေ ၁.၃၀ ထ
ဋေ ၁.၃၆ ထ
ဋေ ၁.၂၅ ထ
Cost of revenue
ဋေ ၁.၂၆ ထ
ဋေ ၁.၃၀ ထ
ဋေ ၁.၃၆ ထ
ဋေ ၁.၂၅ ထ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၁.၀၉ ထ
၈၄၁.၄၀ ဋေ
ဋေ ၁.၆၅ ထ
၉၃၄.၇၀ ဋေ
Operating expense
ဋေ ၂.၅၆ ထ
ဋေ ၁.၈၉ ထ
ဋေ ၁.၇၉ ထ
ဋေ ၂.၁၄ ထ
Total operating expenses
ဋေ ၃.၈၃ ထ
ဋေ ၃.၁၉ ထ
ဋေ ၃.၁၆ ထ
ဋေ ၃.၃၉ ထ
Operating income
ဋေ ၂.၂၂ ထ
၇၁၅.၃၀ ဋေ
၆၇၄.၈၁ ဋေ
၆၃၁.၆၂ ဋေ
Other non operating income
၂၀၀.၆၃ ဋေ
၄၄.၄၆ ကုဋေ
-၂၇၁.၅၄ ဋေ
၆၅.၇၆ ကုဋေ
EBT including unusual items
၉၆၇.၄၀ ဋေ
၅၃၄.၀၀ ဋေ
၃၈၇.၇၇ ဋေ
၆၄၃.၃၉ ဋေ
EBT excluding unusual items
ဋေ ၂.၃၅ ထ
၇၁၈.၃၄ ဋေ
၇၆၁.၁၇ ဋေ
၆၄၃.၃၉ ဋေ
Income tax expense
၃၅၆.၉၇ ဋေ
၁၃၀.၇၇ ဋေ
၈၆.၄၅ ကုဋေ
၁၆၀.၅၆ ဋေ
Effective tax rate
၃၆.၉၀%
၂၄.၄၉%
၂၂.၂၉%
၂၄.၉၆%
Other operating expenses
ဋေ ၁.၃၄ ထ
၈၉၄.၃၆ ဋေ
-၅.၅၆ ကုဋေ
ဋေ ၁.၀၃ ထ
Net income
၆၁၀.၃၅ ဋေ
၄၀၃.၂၁ ဋေ
၃၀၁.၄၁ ဋေ
၄၈၂.၉၂ ဋေ
Net profit margin
၁၀.၀၉%
၁၀.၃၄%
၇.၈၇%
၁၂.၀၂%
Earnings per share
-
၁၉.၂၁
၂၀.၉၆
၁၇.၁၁
Interest and investment income
-
-
၄၁.၃၄ ကုဋေ
-
Interest expense
-၆၆.၄၆ ကုဋေ
-၄၁.၄၃ ကုဋေ
-၄၂.၆၀ ကုဋေ
-၅၄.၀၀ ကုဋေ
Net interest expenses
-၆၆.၄၆ ကုဋေ
-၄၁.၄၃ ကုဋေ
-၁.၂၇ ကုဋေ
-၅၄.၀၀ ကုဋေ
Depreciation and amortization charges
၁၄၁.၂၀ ဋေ
၁၅၄.၄၅ ဋေ
၁၄၇.၉၁ ဋေ
၁၇၃.၁၇ ဋေ
EBITDA
ဋေ ၂.၃၅ ထ
၇၈၀.၄၇ ဋေ
၇၈၀.၀၆ ဋေ
၇၇၄.၉၉ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ